Epinephrine given in the presence of volatile anesthetics can predispose to which dangerous cardiac event?

Epinephrine given in the presence of volatile anesthetics can predispose to which dangerous cardiac event?

• A. They can produce lethal dysrhythmias in the presence of volatile anesthetics.
• B. They reduce the risk of arrhythmias when combined with volatile anesthetics.
• C. They have no interaction with volatile anesthetics.
• D. They cause bradycardia only.

Answer: (A)

The main concept is that epinephrine, when given with volatile anesthetics, can trigger dangerous heart rhythms. Epinephrine elevates sympathetic stimulation—heart rate, contractility, and excitability—while volatile anesthetics make the heart more sensitive to those catecholamines. This combination lowers the threshold for abnormal electrical activity in the ventricles, so the heart is more prone to malignant rhythms such as ventricular tachycardia or ventricular fibrillation, which can be life-threatening. In practice, this is why clinicians are cautious about using high doses of epinephrine while volatile agents are still on board; the risk of lethal dysrhythmias increases. The other options aren’t consistent with this interaction: the pairing does not reduce arrhythmia risk, nor is there no interaction, and epinephrine is not limited to causing bradycardia in this context.

The main concept is that epinephrine, when given with volatile anesthetics, can trigger dangerous heart rhythms. Epinephrine elevates sympathetic stimulation—heart rate, contractility, and excitability—while volatile anesthetics make the heart more sensitive to those catecholamines. This combination lowers the threshold for abnormal electrical activity in the ventricles, so the heart is more prone to malignant rhythms such as ventricular tachycardia or ventricular fibrillation, which can be life-threatening.

In practice, this is why clinicians are cautious about using high doses of epinephrine while volatile agents are still on board; the risk of lethal dysrhythmias increases. The other options aren’t consistent with this interaction: the pairing does not reduce arrhythmia risk, nor is there no interaction, and epinephrine is not limited to causing bradycardia in this context.